Profile
Jin Li is currently Chairman & General Manager at Beijing Orbiepharm Co., Ltd., Director at Beijing Konruns Pharmaceutical Co., Ltd. since 2023, Independent Non-Executive Director at Hightide Therapeutics, Inc., and Independent Non-Executive Director at 3D Medicines, Inc. since 2021.
Formerly, Dr. Li was an Independent Director at Chengdu Easton Biopharmaceuticals Co., Ltd. Dr. Li earned a doctorate from the University of Wisconsin-Milwaukee in 1999.
Jin Li active positions
| Companies | Position | Start |
|---|---|---|
| 3D MEDICINES INC. | Director/Board Member | 25/06/2021 |
| BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. | Director/Board Member | 13/01/2023 |
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | - |
Beijing Orbiepharm Co., Ltd. | Chairman | - |
Former positions of Jin Li
| Companies | Position | End |
|---|---|---|
| CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. | Director/Board Member | - |
Training of Jin Li
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Wisconsin-Milwaukee
University of Wisconsin-Milwaukee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Konruns Pharmaceutical Co., Ltd.
Beijing Konruns Pharmaceutical Co., Ltd. Drugstore ChainsRetail Trade Provides pharmaceutical items | Retail Trade |
Chengdu Easton Biopharmaceuticals Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Hightide Therapeutics, Inc.
Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
Beijing Orbiepharm Co., Ltd. | |
3D Medicines, Inc.
3D Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio-pharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Jin Li
















